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Background: Gestational diabetes mellitus (GDM) – a transitory form of diabetes first recognised during
pregnancy complicates between < 1% and 28% of all pregnancies. GDM has important short and long-term health
consequences for both the mother and her offspring. To prevent adverse pregnancy outcomes and to prevent or
delay future onset of type 2 diabetes in mother and offspring, timely detection, optimum treatment, and preventive
postpartum care and follow-up is necessary. However the area remains grossly under-prioritised.
Methods: To investigate determinants and barriers to GDM care from initial screening and diagnosis to prenatal
treatment and postpartum follow-up, a PubMed database search to identify quantitative and qualitative studies
on the subject was done in September 2012. Fifty-eight relevant studies were reviewed.
Results: Adherence to prevailing GDM screening guidelines and compliance to screening tests seems sub-optimal
at best and arbitrary at worst, with no clear or consistent correlation to health care provider, health system or client
characteristics. Studies indicate that most women express commitment and motivation for behaviour change to
protect the health of their unborn baby, but compliance to recommended treatment and advice is fraught with
challenges, and precious little is known about health system or societal factors that hinder compliance and what
can be done to improve it. A number of barriers related to health care provider/system and client characteristics
have been identified by qualitative studies. Immediately following a GDM pregnancy many women, when properly
informed, desire and intend to maintain healthy lifestyles to prevent future diabetes, but find the effort challenging.
Adherence to recommended postpartum screening and continued lifestyle modifications seems even lower.
Here too, health care provider, health system and client related determinants and barriers were identified. Studies
reveal that sense of self-efficacy and social support are key determinants.
Conclusions: The paper identifies and discusses determinants and barriers for GDM care, fully recognising
that these are highly dependent on the context.
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Affecting between <1% and 28% of all pregnancies gesta-
tional diabetes mellitus (GDM) is a fairly common medical
condition associated with pregnancy in many settings [1].
As the epidemic of diabetes and pre-diabetes in the
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reproduction in any medium, provided the orincreasing age of conception and child bearing, the rates of
GDM will continue to rise as already seen in some studies
[2-4]. GDM was earlier defined as “hyperglycaemia first rec-
ognized during pregnancy” and has more recently (2012)
been described by the American Diabetes Association
(ADA) as diabetes diagnosed during pregnancy that is
not clearly overt diabetes [5]. GDM has health conse-
quences for both the mother and her offspring not only
in the short term but also in the long term. It is well estab-
lished that women with GDM are at increased risk of
adverse pregnancy outcomes [6,7], as well as, several foldLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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compared to women without GDM [8,9]. Studies show
that achieving glycaemic control with lifestyle modi-
fications and/or pharmaceutical intervention during preg-
nancy prevents or considerably reduces the risk of adverse
pregnancy outcomes [10,11]. Clinical trials provide evi-
dence that lifestyle modifications as well as pharmaco-
logical interventions can prevent progression to type 2
diabetes in women with a history of GDM and these inter-
ventions are as effective as in people with pre-diabetes
[12-14]. Effective intervention requires universal antenatal
screening for GDM, optimal treatment and adherence,
and rigorous postpartum follow-up and preventive care.
Nielsen et al. recently pointed out the urgent need for
universally applicable simple screening and diagnostic
procedures criteria for GDM [15]. In this paper we at-
tempt to identify determinants and barriers to implement-
ing effective and integrated public health initiatives to
address screening, diagnosis, treatment and postpartum
care for GDM based on a review of published studies on
the subject.
Methods
We reviewed the literature to assess existing evidence on
determinants and barriers for GDM services in high-,
middle- and low-income countries. GDM services were
understood as 1) screening and diagnosis 2) treatment
during pregnancy 3) postpartum diabetes testing and 4)
continuation of postpartum lifestyle modification.
Search strategy
PubMed database was searched in September 2012 using
the terms “GDM/gestational diabetes mellitus/‘diabetes’
and ‘pregnancy’” in combination with one of the terms
“barrier/barriers/challenge/challenges/determinant/deter-
minants/utilization/use/access/lifestyle change/self-ef-
ficacy/social support”. The Mesh terms “gestational
diabetes mellitus” and “access to health care” were
also used.
Study selection, eligibility criteria and data abstraction
Studies that only examined pre-gestational diabetes
whether type 1 or type 2 diabetes were excluded as were
studies where specific information on women with
GDM was not available. The list of citations was scanned
and qualitative and quantitative research studies with
relevant titles examining determinants and/or barriers to
GDM services and related aspects, e.g. compliance to
treatment, were included. The abstracts of these studies
were read and those with an abstract and subsequent
full-text reading indicating relevance to the purpose of
this review were selected. Finally, the reference lists of
the selected publications were manually searched for
additional relevant articles.Results
Search outcome
A total of 1578 unique citations were identified; 977
were excluded based on the title and another 500 were
excluded after reading the abstract. Of the remaining
101, three papers were non English language (1 from
Poland, Spain and Mexico, respectively) and excluded.
The remaining 98 articles were read for relevance for
this review and a further 55 were excluded because of
lack of relevance i.e. studies did not look at determinants
or barriers to GDM services. One article was added
following suggestion from experts and 14 others were
added after going through the reference lists of included
articles. Thus, a total of 58 papers were included in this
review (see Figure 1).
The studies included are listed in Tables 1, 2 and 3. The
majority are from high-income countries: USA (N = 28),
Canada (N = 8), Australia (N = 10), New Zealand (=1) and
European countries (N =7) and only four from low- and
middle-income countries.
Determinants and barriers for GDM screening
Ensuring timely detection of GDM is a prerequisite for ini-
tiation of treatment and prevention of adverse outcomes
due to GDM. Only a few relevant studies related to GDM
screening were identified, and they mostly looked at deter-
minants of compliance to screening recommendations.
Characteristics of health care providers and health care
setting
In the US over 20 years ago with various screening
approaches available and no clear consensus on which
one to follow, Marreo et al. and Landon et al. conducted
two explorative studies on GDM screening and care
practices [16,17]. Marrero et al. examined practice differ-
ence between family physicians and physicians specialis-
ing in obstetrics/gynaecology and found that the former
were less likely to screen all pregnant women for GDM
compared to latter (75% vs. 83%; P = 0.033) [17]. Landon
et al. investigated differences in screening practices among
members of the Society of Perinatal Obstetricians (SPO)
and members of the American College of Obstetricians
and Gynaecologists (ACOG) and found that a significantly
higher proportion of the former practiced universal
screening for GDM compared to the latter [16]. A more
recent study by Sievenpiper et al. [18] looked at whether
the category of health care provider ordering a 2-step test
as recommended by the Canadian Diabetes Association
influenced if the recommendation was followed appropri-
ately i.e. whether an oral glucose tolerance test (OGTT)
was completed and found no association. Gazmararian
et al. [19] assessed whether the gender of the obstetrician
and years since graduation influenced if the glucose chal-
lenge test was undertaken, and found that the likelihood
Figure 1 Flow chart of study search and selection.
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30 years, while gender had no significant effect. The
authors acknowledged that glucose challenge test recom-
mendations were not universally adhered to, but did
not believe that time since graduation explained the
differences in test executions.
A rather unusual finding was reported by Ruengkhachorn
et al. from Thailand, where compliance to screening
guideline recommending universal screening was 88% in
women at risk of GDM attending a non-private hospital
setting in Bangkok, but only half amongst women attend-
ing the antenatal care (ANC) clinic at a private hospital
and none amongst those attending a private clinic. The
authors hypothesised that the difference may be due to
concerns of inconvenience, cost of test or negligence of
the physicians themselves, and noted that a screening
guideline had not been fully implemented at the private
hospital [20]. Contrary to this, Moses et al. in their study
from Australia where screening of all pregnant women is
recommended found that women attending ANC at
public hospitals were less likely to be screened for GDMcompared to women attending ANC at general practi-
tioners’ or obstetricians’ private practices [21].
Client characteristics: ethnicity, body weight and age
Ethnicity
A study from New Zealand – a country with universal
screening recommendation for GDM, found that only
half of the women attending ANC were screened; being
of non-European ethnicity significantly increased the
likelihood; but still a large proportion of women with
risk factors were not screened [22]. Ethnicity was also
identified as a significant determinant for GDM screen-
ing by Blatt and colleagues in their study from the US,
where non-white ethnicity increased the likelihood of
being screened [23]. Two studies by Cullinan and col-
leagues have investigated determinants of GDM screen-
ing in Ireland where no single policy on GDM screening
is implemented, but the local authorities in the region
where the studies were conducted advocate a universal
screening approach. The data in the studies are over-
lapping in the sense that one paper uses data from five
Table 1 Overview of articles focusing on screening (n = 12) (alphabetic order)
Article Country Study design Study population Focus
Blatt et al. (2011) [23] USA Review of data from
Quest Diagnostics
924,873 pregnant women Characteristics of
pregnant women
Cullinan et al. (2012a) [24] Ireland Hospital clinical data 9,842 pregnant women Characteristics of the
pregnant women
Cullinan et al. (2012b) [25] Ireland Hospital clinical data 4,414 pregnant women Characteristics of the
pregnant women
Gazmararian et al. (1996) [19] USA Review of prenatal
care records
2,184 pregnant women Characteristics of health
care providers
Characteristics of the
pregnant women
Landon et al. (1990) [16] USA Cross-sectional mail
survey
471 obstetricians and
maternal-fetal specialists
Characteristics of health
care providers
Marrero et al. (1992) [17] USA Mail survey 668 family practice physicians
and obstetricians/gynaecologists
Characteristics of health
care providers
Moses et al. (2003) [21] Australia Review of medical
records
1,648 pregnant women Characteristics of health
care setting
Nielsen et al. (2012) [15] Various developing countries Qualitative. Interviews
and questionnaire.
10 GDM project implementers Barriers mentioned by
project implementers
Pedula et al. (2009) [26] USA Review of medical records 21,758 pregnancies Characteristics of the
pregnant women
Ruengkhachorn (2006) [20] Thailand Review of antenatal
care records
159 pregnant women Characteristics of health
care setting
Characteristics of the
pregnant women
Sievenpiper et al. (2012) [18] Canada Audit 1,026 pregnant women Characteristics of health
care providers
Characteristics of the
pregnant women
Yapa & Simmons (2000) [22] New Zealand Review of hospital
medical records
4,885 pregnant women Characteristics of the
pregnant woman
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only includes data from the largest of these five centres.
Ethnicity was not found to be a statistically significant
determinant in either of the papers [24,25]. Pedula and
colleagues reported differences in the proportion screened
among different ethnic groups in a hospital setting in
Hawaii with a policy that GDM screening should be
routinely done among pregnant women [26].
BMI and body weight
The American College of Obstetrics and Gynecologists
recommends that all pregnant women without known
diabetes should have their risk for GDM assessed by
reviewing their history, clinical risk factors, including
overweight/obesity, or by having laboratory screening
tests done [27]. Yet, in their study from the US, Blatt et al.
found that women weighing more than 275 pounds
(125 kg) were 12% less likely to have a glucose tolerance
test than the women in the reference group who weighed
100–124 pounds (45–56 kg) [23]. However, whether the
women in the higher weight category had their clinical
risk factors assessed and subsequent intervention initiatedis not stated. Cullinan et al. found in both their studies
that having a BMI over 30 kg/m2 significantly increased
the likelihood of screening although this was not the case
for overweight women with a BMI between 25 and 30
[24,25]. Likewise, Yapa & Simmons in their study from
New Zealand also found that higher body weight signifi-
cantly increased the likelihood of screening in an environ-
ment where universal screening is recommended [22].
Age
Several studies have investigated age as a determinant
for screening. Despite the policy stating that GDM
screening should be routinely done among pregnant
women, Pedula et al. found that a higher proportion of
younger women (≤ 25 years) rather than older women
were screened [26]. Cullinan et al. and Blatt et al. found
that older women were more likely to be screened than
their younger counterparts [23-25]. In Cullinan et al.'s
studies universal screening was advocated locally but not
nationally, whereas in the study by Blatt et al. the
recommendation is that women should have a glucose
test or their clinical risk factors/patient history assessed.
Table 2 Overview of articles focusing on treatment (n = 15) (alphabetic order)
Article Country Study design Study population Focus
Bandyopadhyay et al. (2011) [29] Australia Qualitative. Semi-structured
interviews.
17 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Collier et al. (2011) [39] USA Qualitative. Focus group
discussions.
4 focus group discussion
with women with GDM
Barriers mentioned by women
with GDM
Doran & Davis (2010) [30] Tonga Qualitative. Semi-structured
interviews
11 women with GDM Experiences of living with GDM
Barriers mentioned by health
care providers
Barriers mentioned by women
with GDM
Evans & O’Brien (2005) [31] Canada Qualitative. Interviews 12 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Hirst et al. (2012) [38] Vietnam Qualitative. Focus group
discussions
4 focus group discussions
with women with GDM
Experiences of living with GDM
Barriers mentioned by women
with GDM
Hjelm et al. (2007) [36] Sweden Qualitative. Semi-structured
interviews
27 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Hjelm et al. (2008) [37] Sweden Qualitative. Semi-structured
interviews
23 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Landon et al. (1990) [16] USA Cross-sectional mail survey 471 obstetricians and
maternal-fetal specialists
Characteristics of health care
providers
Lawson & Rajaram (1994) [32] USA Qualitative. Interviews 17 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Marrero et al. (1992) [17] USA Mail survey 668 family practice physicians
and obstetricians/gynaecologists
Characteristics of health care
providers
Mersereau et al. (2011) [40] USA Qualitative. Focus group
discussions
6 focus groups with health
care providers
Barriers mentioned by health
care providers
Neufeld (2011) [33] Canada Qualitative. Semi-structured
interviews
29 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Persily (1996) [35] USA Convenience sample of
women with GDM followed
from diagnosis through delivery
29 women with GDM Experiences of living with GDM
Persson et al. (2010) [34] Sweden Qualitative. Interviews 10 women with GDM Experiences of living with GDM
Barriers mentioned by women
with GDM
Ruggiero et al. (1990) [28] USA Cross-sectional survey 98 women with GDM Role of psychosocial factors
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ences probability of screening, indicating an underlying
tendency to rely on risk factor based screening. On the
other hand, Yapa & Simmons did not find a significant
association between age and screening for GDM in their
setting where universal screening was recommended [22].
Similarly, Sievenpiper et al. found that maternal age did
not affect the probability that the recommended 2-step
approach was followed, as also the study by Gazmararianet al. who found no statistically significant association
between maternal age and screening for GDM in an
environment with no consensus on the screening ap-
proach [18,19].
Other factors
Gazmararian et al. also investigated whether marital
status and trimester of entry to ANC influence the
likelihood of a glucose challenge test being administered,
Table 3 Overview of articles focusing on postpartum follow-up (n = 36) (alphabetic order)
Article Country Study design Study population Focus
Almario et al. (2008) [41] USA Review of data from Laboratory
Corporation of America and
Quest Diagnostics
90 women with GDM Characteristics of health
care setting
Characteristics of services/
treatment received
Characteristics of women
with GDM
Baker et al. (2009) [48] USA Mail survey 399 health care providers Characteristics of health
care providers
Barriers mentioned by
health care providers
Bandyopadhyay et al. (2011) [29] Australia Qualitative. Semi-structured
interviews.
17 women with GDM Experiences of living
with GDM
Barriers mentioned by
women with GDM
Beischer et al. (1997) [47] Australia Cohort study using data
from GDM follow-up
programme
2,939 women with GDM Characteristics of health
care setting
Characteristics of services/
treatment received
Characteristics of women
with GDM
Bennett et al. (2011) [61] USA Qualitative. Semi-structured
interviews.
22 women with GDM Barriers mentioned by
women with GDM
Blatt et al. (2011) [23] USA Review of data from Quest
Diagnostics
40,955 women with GDM Characteristics of women
with GDM
Clark et al. (2009) [55] Canada Randomized controlled trial 223 women with GDM Characteristics of services/
treatment received
Dietz et al. (2008) [46] USA Kaiser Permanente
Northwest data
461 women with GDM for
first part of the study and
356 for second part.
Characteristics of health
care setting
Characteristics of services/
treatment received
Characteristics of women
with GDM
Ferrara et al. (2009) [58] USA Review of medical records 14,448 women with GDM Characteristics of women
with GDM
Characteristics of services/
treatment received
Gabbe et al. (2004) [49] USA Mail survey 569 obstetricians/
gynaecologists
Characteristics of health
care providers
Graco et al. (2009) [70] Australia Qualitative. Interviews 10 women with GDM Barriers mentioned by
women with GDM
Hoedjes et al. (2012) [62] The Netherlands Qualitative. Focus
group discussions
5 women with GDM Barriers mentioned by
women with GDM
Hunt & Conway (2008) [59] USA Prospective cohort study 707 women with GDM Characteristics of women
with GDM
Characteristics of services/
treatment received
Kaufmann et al. (1999) [53] USA Cross-sectional survey 66 women with GDM Characteristics of health
care providers
Characteristics of women
with GDM
Keely et al. (2010) [50] Canada Fax and telephone survey 173 primary care providers
and 140 women with GDM
Barriers mentioned by
health care providers
Barriers mentioned by
women with GDM
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Table 3 Overview of articles focusing on postpartum follow-up (n = 36) (alphabetic order) (Continued)
Kim et al. (2008) [67] USA Cross-sectional survey 228 women with GDM Role of psychosocial factors
Kim et al. (2007) [57] USA Cross-sectional survey 217 women with GDM Experience of risk of
future diabetes
Kim et al. (2007a) [65] USA Cross-sectional survey 228 women with GDM Characteristics of services/
treatment received
Kim et al. (2006) [42] USA Review of hospital
medical records
533 women with GDM Characteristics of women
with GDM
Characteristics of health
care providers
Characteristics of services/
treatment received
Koh et al. (2010) [68] Australia Cross-sectional
telephone survey
331 women with GDM Characteristics of women
with GDM
Role of psychosocial factors
Kwong et al. (2009) [60] Canada Retrospective
cohort study
909 women with GDM Characteristics of women
with GDM
Characteristics of services/
treatment received
Lawrence et al. (2010) [43] USA Kaiser Permanente
Southern California Medical
Care Program data
11,825 women with GDM Characteristics of services/
treatment received
Characteristics of women
with GDM
Morrison et al. (2009) [49] Australia Cross-sectional mail survey 1,372 women with GDM Characteristics of health
care providers
Characteristics of women
with GDM
Characteristics of services/
treatment received
Neufeld (2011) [33] Canada Qualitative. Semi-structured
interviews
29 women with GDM Experiences of living
with GDM
Barriers mentioned by
women with GDM
Nicklas et al. (2011) [71] USA Qualitative. Interviews and
focus group discussions
3 focus group discussions
with women with GDM,
and interviews with 15
women with GDM
Barriers mentioned by
women with GDM
Razee et al. (2010) [72] Australia Qualitative. Semi-structured
interviews.
57 women with GDM Barriers mentioned by
women with GDM
Russell et al. (2006) [54] USA Retrospective cohort study 344 women with GDM Characteristics of health
care setting
Characteristics of women
with GDM
Shah et al. (2011) [51] Canada Population-level health
care database
47,691 women with GDM Characteristics of health
care providers
Shea et al. (2011) [56] Canada Hospital laboratory and
provincial physician service
claims databases
262 women with GDM Characteristics of services/
treatment received
Characteristics of women
with GDM
Smirnakis et al. (2005) [45] USA Review of medical records 197 women with GDM Characteristics of health
care providers
Characteristics of women
with GDM
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Table 3 Overview of articles focusing on postpartum follow-up (n = 36) (alphabetic order) (Continued)
Smith et al. (2005) [64] Australia Telephone survey 226 women with GDM Barriers mentioned by
women with GDM
Role of psychosocial factors
Stage et al. (2004) [66] Denmark Mail survey 121 women with GDM Experience of risk of
future diabetes
Stuebe et al. (2010) [52] USA Survey 207 primary care providers
and obstetrics & gynaecology
care providers
Characteristics of health
care providers
Barriers mentioned by
health care providers
Swan et al. (2007) [69] Australia Mail survey 53 women with GDM Characteristics of women
with GDM
Symons Downs & Ulbrecht (2006) [73] USA Mail survey 28 women with GDM Barriers mentioned by
women with GDM
Zehle et al. (2008) [63] Australia Telephone survey 226 women with GDM Role of psychosocial factors
Characteristics of women
with GDM
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[19]. Cullinan and colleagues noted that greater distance
to the screening site, residing in an urban, richer part of
town and high parity decreased the likelihood of partici-
pating in screening in a setting where universal screen-
ing was advocated. In addition, a positive family history
of diabetes did not significantly affect the decision to
attend GDM screening [24,25]. Furthermore, Sievenpiper
et al. found that a borderline result of the 50 g glucose
challenge test (GCT) did not predict if an OGTT would
be performed as stated in the guideline [18]. In spite of
the guideline on universal screening, Ruengkhachorn et al.
found that compliance to screening was more likely
amongst women with two or more risk factors for GDM
compared to those with only one risk factor [20].
These studies indicate that even in developed countries
adherence to prevailing guidelines for GDM screening
and compliance to screening tests seems sub-optimal
at best and arbitrary at worst. Very little information,
if any, is available on factors that favour or deter
screening and provide pointers to what can be done
to improve it.
Barriers for GDM screening
Nielsen et al. interviewed the implementing partners
of 11 GDM projects funded by the World Diabetes
Foundation in various developing countries and found
various challenges in GDM screening and diagnosis in-
cluding difficulties in screening women during the recom-
mended time period, applicability and relevance of the
risk factors used in selective screening programmes,
challenges in testing women in the fasting state and
need for repeated testing, screening procedure being
too time consuming, scarcity of test consumables and lack
of equipment etc. [15].Determinants of and barriers for GDM treatment
While there are only a few studies looking at determinants
and barriers for screening as indicated in the foregoing,
studies to assess determinants and barriers for GDM
treatment are more extensive. Again, the majority of stud-
ies are from high-income countries (13 out of 15).
In their study from Indiana, US, published back in
1992, Marrero et al. examined the specialisation of the
health care provider in relation to insulin prescription
for GDM and found that family physicians were more
likely to initiate insulin therapy than obstetricians [17].
Landon et al. found that the method for glucose surveil-
lance differed greatly among members of the American
College of Obstetrics and Gynecologists (ACOG) depen-
ding on the post training duration of practice (≥ 15 years
or ≤ 15 years) and with members of the Society of
Perinatal Obstetricians (SPO). Use of insulin was more
frequent among SPO members who also used lower glu-
cose thresholds for initiating insulin compared to ACOG
members [16]. Ruggiero et al. investigated the role of
social support and dietary and insulin therapy compli-
ance, and found a significant positive correlation; social
support accounted for 10 and 24% variance in reported
compliance to dietary advice and insulin therapy, res-
pectively [28].
Other studies have taken a more anthropological ap-
proach to understanding the determinants and barriers to
GDM treatment. Six qualitative studies with focus on
women’s experiences with GDM diagnosis were identified
in our search. Most women expressed commitment and
motivation to manage their diabetes during pregnancy to
protect the health of the unborn baby, but behaviour
changes, and compliance to treatment were fraught with
challenges [29-34]. Two studies found that women inter-
viewed later in their pregnancy had acquired familiarity
Nielsen et al. BMC Pregnancy and Childbirth 2014, 14:41 Page 9 of 18
http://www.biomedcentral.com/1471-2393/14/41with their diabetes, and reported greater ability to cope
with the stress as the treatment became part of a normal
daily routine [31,34]. Persson et al. also noted that such
adaptation was easier to achieve for women with GDM in
a previous pregnancy [34]. In addition, both Evans &
O’Brien and Persson et al. reported that women described
their experience as if being controlled by the disease, their
families and health care providers; with their behaviour
under surveillance, and as if their blood glucose levels
determined if they were ‘good mothers’ [31,34] and that
delivery was the ‘moment of truth’ when maternal and
fetal outcomes were revealed [34]. Lawson & Rajaram
reported feelings amongst women with GDM: numb with
fear for the baby’s wellbeing, guilt and being personally
responsible for the disorder, anxious about the future and
distressed with the treatment, losing autonomy when
hospitalised and an inability to control the illness. It was
also reported that these feelings affected their own percep-
tion of self-worth [32]. In a quantitative study from 1996,
Persily reported that women who perceived GDM to have
a greater stress on their lives were less likely to self-
monitor their blood glucose [35]. Hjelm et al. studied
perceptions about treatment amongst women with GDM
attending a specialised diabetes clinic in Sweden [36].
Limited access and waiting time to meet health care
providers coupled with their perceived lack of competence
caused anxiety and loss of confidence; whereas provision
of adequate information reduced anxiety and gave women
a feeling of control over the situation [36]. In another
study by Hjelm et al., cost of healthy food and lack of
advice and information about exercise in relation to GDM
and waiting time to access health care providers for advice
were mentioned by women with GDM as important
barriers [37]. In her study about food perceptions and
concerns among aboriginal women with GDM in Canada,
Neufeld points out a number of emotional and psycho-
logical challenges related to dietary management during
pregnancy: women found it difficult to adhere to the
dietary management plan due to pregnancy-related food
preferences and cravings, plans being perceived as
stressful, adaptation of unhealthy eating patterns such
as ‘bulimia and binging’, and frequent use of ‘comfort
foods’. Women mentioned that dietary messages were
sometimes contradictory, lacked adequate practical in-
formation and they did not trust the nutrition edu-
cation messages received from health care providers
[33]. Confusion over dietary recommendations, lack of
sufficient advice and concerns about the effects of the
recommendations were also pointed out by Hirst et al. in
their study from Vietnam [38] as well as the study by
Lawson & Rajaram from the US [32]. From a study on
immigrant South Asian women with GDM in Australia,
Bandyopadhyay et al. reported difficulties in under-
standing dietary recommendations [29]. In addition, foodpreferences and cravings, concerns for baby’s growth and
fear that too much physical activity would put a strain on
the baby were other concerns that hindered compli-
ance to diet and exercise recommendations during GDM
pregnancy [29].
Two recent qualitative studies from the US have spe-
cifically looked at barriers to treatment [39,40]. Collier
et al. conducted focus group discussions with women
who had GDM or pre-gestational diabetes during a re-
cent pregnancy. Women mostly reported financial bar-
riers e.g. cost of health care, medical supplies and food,
but also barriers related to access to care and insurance,
and related to physical activity and maintaining healthy
diet; difficulties in finding information and communicat-
ing with health care providers; lack of social support;
and barriers related to care, e.g. reluctance to inject in-
sulin and treatment being seen as time consuming [39].
Mersereau et al. conducted focus group discussions with
health care providers to investigate barriers to good gly-
caemic control in women with GDM [40]. The barriers
identified by the health care providers were lack of
knowledge and awareness among the women with
GDM, lack of access, including financial and insurance
issues, attitudinal barriers such as denial of the severity
of the disease, no motivation, lack of compliance, and
social barriers. The authors note that most of the health
care providers perceived the barriers to be outside their
locus of control [40]. Other barriers or challenges noted
in studies include difficulty in adhering to a diet when
participating in social gatherings [31,34], and insufficient
social support hampering compliance to treatment [34].
Finally, Doran & Davis in their study from Tonga high-
light structural changes such as more cars leading to
reduced physical activity, more unhealthy take away
food options and lower rates of home cooking and
eating of traditional foods, as factors contributing to
unhealthy lifestyle and difficulties in adherence to
treatment [30].
Hence, with regard to treatment and factors influ-
encing it, the published literature does provide some
direction. The majority of studies focusing on treat-
ment has been qualitative and found that women express
motivation and show commitment to manage their
diabetes, but that several challenges exist. Social sup-
port has been identified in qualitative studies to be
key to proper management of diabetes in pregnancy and
data from the quantitative study by Ruggiero et al. sup-
ports this finding.
Determinants and barriers for postpartum diabetes screening
The literature dealing with postpartum follow-up of
women with GDM is either focussed on postpartum
screening for diabetes or prevention of type 2 diabetes in
terms of maintaining healthy lifestyles.
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Screening for diabetes following an index GDM preg-
nancy is in general reported to be low. Depending on
the definition of ‘postpartum diabetes screening’ including
the type of test and follow-up period, studies identified in
this review – all from the US or Australia – found post-
partum diabetes screening rates ranging from 19 to 73%
[23,41-45]. Studies that have assessed the frequency of
postpartum screening over time show that the proportion
of women with GDM completing a postpartum screening
test has increased; thus between 1999 and 2004 Dietz
et al. found that the proportion of women with confirmed
GDM who completed a postpartum screening test within
3 months increased from 9 to 58% in their research setting
in north-west US [46]. In their study from Australia,
Beischer et al. found that overall postpartum follow-up
attendance was 71% and attendance had increased from
43.7% in 1981 to 84.4% in 1995 [47].
A number of studies have examined possible deter-
minants for postpartum screening. Three studies investi-
gated how frequently health care providers screen women
with GDM for diabetes postpartum [48-50]. In their study
from US, Baker et al. found that only 21% of respondents
always screen for diabetes postpartum, whereas Keely
et al. reported that 37% of primary care providers in
Ottawa, Canada had their GDM patients complete a post-
partum OGTT [48,50]. Gabbe et al. reported that 74% of
obstetricians and gynaecologists in the US routinely
performed a postpartum evaluation of glucose intolerance
in women diagnosed with GDM and physicians younger
than 40 years of age were more likely to routinely perform
postpartum tests (87.6% vs. 73.2%, p = 0.005) [49]. Shah
et al. found that internists/endocrinologists in Ontario,
Canada ordered the majority of postpartum diabetes
screening test and obstetricians the fewest [51], and
Stuebe and colleagues found primary care providers being
more likely than OBGYN specialists in Massachusetts,
US, to order a postpartum screening test for women
with a known history of GDM [52]. In contrast,
Baker et al. and Kaufmann et al. found in their
studies from the US that physicians’ speciality did
not significantly influence the likelihood of postpar-
tum testing [48,53].
Morrison et al. assessed two-way interactions and
found that being under the care of an endocrinologist
insignificantly increased the likelihood of postpartum
screening among less educated Australian women, and
being seen by a diabetes educator significantly increased
the likelihood of postpartum screening among Australian
women under the care of an obstetrician [44]. Kim et al.
investigated different scenarios to predict postpartum
glucose testing in a university hospital in Michigan, USA.
After adjusting for confounders the only scenario thatsignificantly predicted testing was a visit to an endocrin-
ologist after delivery [42].
Almario et al. looked at the effect of the gyn/obst-spe-
cialists’ practice setting (‘office type’) and found that gyn/
obst-specialists working in a high-risk pregnancy setting
in the US were more likely to provide postpartum diabetes
screening compared to their colleagues working in a nor-
mal (non-high risk) pregnancy setting [41]. Likewise, in
their study also from the US, Dietz et al. found that prac-
tice site was predictive of clinician ordering the test but
not for the test being actually taken [46]. Smirnakis et al.
studied a population of women with a history of GDM in
Massachusetts, US, and found that practice site had a
borderline effect on postpartum screening in univariate
analysis, but not after adjustment for potential confoun-
ders [45]. Moreover, Russell et al. reported that type of
referral clinic did not predict postpartum testing in their
study from Rhode Island, US [54].
Reminders and advice on postpartum screening have
been assessed by four studies. Hence, two studies from
Canada found that receiving reminders about testing
increased the likelihood of testing [55,56]. Similarly, an
Australian study by Morrison et al. found that providing
postnatal written information or individualised risk re-
duction advice significantly increased the likelihood for
postpartum screening [44], and in the US, Kim et al.
found that women who recalled receiving advice on
postpartum screening were more likely to report actually
being tested [57].
Finally, the immediate postpartum OGTT was found
to be an important predictor of subsequent follow-up
test in a study by Beischer et al. from Australia. The
study moreover noted that whereas patients attending a
public clinic were more likely to receive postpartum
OGTT, private patients who received the postpartum
test were more likely to be enrolled in the long-term
follow-up programme [47].
The studies focusing on identifying health care
provider- or health care setting-related determinants for
postpartum screening show that often postpartum screen-
ing rates are sub-optimal. Studies that focus on the health
care provider or setting seem not to provide a clear pic-
ture, but this may be due to different practice between
countries and/or over time. Yet, receiving reminders or
postnatal information appear to have a positive impact on
the likelihood of postpartum screening, as does recollec-
tion of receiving advice on postpartum testing. For longer-
term follow-up it has been indicated that the immediate
postpartum test and attendance in a private clinic may be
predictors, at least in Australia.
Barriers according to health care providers
Three studies – two from the US and one from Australia -
reported on health care providers’ perceptions of barriers
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Barriers mentioned were diverse: not seeing the patient,
the patient being lost to follow-up and lack of commu-
nication/collaboration between health care providers were
the most widely mentioned issues. Other barriers men-
tioned were inconsistent guidelines or lack of familiarity
to guidelines; not aware about history of GDM; patients
not considering the test necessary, or declining testing, or
unable to complete test; testing not affordable; patient
uninformed or lack understanding of need for test, and
practice being too busy etc. [48,50,52].
Characteristics of the client with GDM
Studies from high-income countries have also focused
on client characteristics and other determinants for post-
partum diabetes screening.
Studies from the US conducted by Almario et al. and
Ferrara et al. found that women had an increased like-
lihood of being screened postpartum if their GDM
was diagnosed early - before 24 weeks and 20 weeks of
gestation, respectively - compared to women later in
pregnancy [41,58]. In contrast, Hunt & Conway did not
find a significant association between gestational age at
diagnosis and glucose testing postpartum [59]; but they
found that women missing the postpartum testing had
higher fasting and 1-h OGTT glucose levels at GDM
diagnosis [59]. Almario et al. noted that women diag-
nosed with a GCT had an increased likelihood of post-
partum screening compared to women diagnosed with
GDM using a 3-h 100 g OGTT [41]. Blatt et al. found
that women who did not return for postpartum testing
had significantly lower glucose concentration in their
2-h OGTT than those who returned [23]. Other stud-
ies from the US found no significant effect of the results
of the fasting or the OGTT on postpartum screening
irrespective of the glucose load [42,58]. Smirnakis et al. in
their study from Massachusetts, US [45] also found no
significant effect of the 1-h, 2-h and 3-h OGTT re-
sults, but found that women with glucose concentra-
tions ≥ 98 mg/dl (5.4 mmol/l) in their fasting glucose
test or ≥171 mg/dl (9.5 mmol/l) at 1-h at the 50 g
GCT were more likely to undergo postpartum screen-
ing than were women with concentrations below these
levels. Similarly Beischer et al. from Australia found that
the results of the 50 g GCT significantly predicted both
enrolment and maintenance in postpartum follow-up
screening program [47]. Kwong et al. however found no
significant association between the results of the 50 g
GCT and postpartum screening in their study from
Canada [60]. Studying a population in the US, Hunt &
Conway found that women not returning for postpartum
testing had higher mean fasting, preprandial and 2-h
postprandial glucose levels during pregnancy [59]. Kim
et al. included total number of prenatal visits in their studymodel conducted on data from Michigan, but found that
it did not predict postpartum glucose testing when inclu-
ded in multivariate analysis [42]. Dietz et al. and Hunt &
Conway have both looked at the timing of the test during
pregnancy, but found that it neither influenced postpar-
tum test order and test completion [46] nor whether the
women returned for postpartum screening [59]. On the
other hand attending a postpartum visit with an OBGYN
provider was found to greatly increase the likelihood of
postpartum glucose testing in two other studies from the
US [43,54] and if conducted within 3 months of delivery it
also increased the likelihood of completing the test [46].
Multiple visits were likewise shown to be positively associ-
ated with postpartum testing [42,58].
Ten studies have assessed the effect of treatment type
for GDM on postpartum glucose testing. Six of these
were from the US, including the study by Almario et al.
which found that women receiving pharmacotherapy
during pregnancy (treated with insulin or glyburide as a
combined variable) were more likely to be screened com-
pared to women treated with diet [41]. Hunt & Conway
on the other hand found that women who failed to return
for postpartum testing were more likely to have had
required medication to treat their GDM [59]. Dietz et al.
investigated predictors for physician ordering postpartum
glucose testing and for test completion and found that use
of insulin or glyburide during pregnancy was not signifi-
cantly associated with these outcomes [46]. Studies from
the US have also looked at the use of insulin and glyburide
as two independent variables. Ferrara et al. and Hunt &
Conway looked at glyburide, but whereas Ferrara et al.
found that the use of glyburide increased the likelihood of
postpartum glucose testing [58] Hunt & Conway did not
find a statistically significant difference in the use of gly-
buride among women who returned and did not return
for postpartum testing [59]. Six studies have looked at in-
sulin use, but their results differ: two studies from the US
and one from Australia found no significant association
with use of insulin and postpartum glucose screening
[42-44], one study from the US and two studies from
Canada found on the other hand that insulin signifi-
cantly predicted postpartum glucose testing [56,58,60].
In addition, Beischer et al. found that requiring insulin
during pregnancy predicted enrolment and maintenance
in follow-up program for postpartum testing in Australia
[47], but Hunt & Conway found that women in their
US population who failed to return for postpartum
testing were more likely to have used insulin [59]. Finally,
Lawrence et al. found that the use of oral agents alone
decreased the likelihood of testing among their study
population from Southern California [43].
Studies from the US looking at self-monitoring [59]
and nutrition visit during pregnancy [46], as well as a
Canadian study focusing on HbA1c level during pregnancy
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When assessing obstetrical history as a predictor for
postpartum testing studies found no significant associa-
tions with gravidity [42,53], number of prior pregnancies
with GDM [41], prior macrosomia [59], multiple births
with affected pregnancy [42], prior history of preeclamp-
sia or eclampsia [42]. When it comes to the role of par-
ity [43,46,53,54,58-60], study results from the US and
Canada, are inconsistent. Kaufmann et al. included subse-
quent pregnancies in their analysis on US data but found
no association with postpartum testing [53]. Hunt & Con-
way found that women who failed to return for postpar-
tum glucose testing were more likely to have a history of
GDM compared to women who returned [59], but other
studies from the US as well as from Australia and Canada
investigating the effect of previous GDM on postpartum
testing did not find statistically significant associations
[42,44,54,56,60].
Studies from the US have also investigated whether
occurrences in the current GDM pregnancy influences
the likelihood of postpartum glucose testing, but the
findings are no different from studies looking at occur-
rences in past pregnancies, and no significant association
is found between preeclampsia [59], gestational week at
delivery [42,54,59], having a caesarean delivery [43,54,59],
macrosomia [42,46,58,59], live birth [42], need for neo-
natal intensive care [54] and postpartum diabetes testing.
However, Lawrence et al. found that year of delivery sig-
nificantly influenced the likelihood of postpartum glucose
testing within 6 months from delivery, with women deliv-
ering in the years 2000 to 2006 having a higher likelihood
for testing than women in 1999 [43]. The Australian study
by Beischer et al. similarly found that the year of the preg-
nancy influenced the likelihood of enrolment in postpar-
tum testing programme [47].
Two studies from the US investigated the effect of
weight gain during pregnancy and one looked at weight
changes in general, but none of them found a significant
association with postpartum testing [42,53,59]. Hunt &
Conway in addition found that women who did not
return for postpartum glucose testing weighed more
prior to pregnancy than those who returned [59]. Other
studies focusing on maternal weight likewise found that
obesity or increasing weight significantly reduced the like-
lihood of testing [23,58]. Studies focusing on BMI are
available from US, Australia and Canada; however, they
have in general not found any significant association with
postpartum glucose testing. Hence, only one – a study
from Canada - of the nine studies assessing BMI as a
predictor for screening [41,42,44-46,54,56,59,60] found a
significant association with women being normal or over-
weight being more likely to go for any postpartum glucose
testing than obese women [56].Equally variable results are seen when it comes to
assessing whether age, income, education, ethnicity/
race and marital status are predictors of screening
[23,41-47,53,54,56,58-60]. One study from Australia
and two from the US investigated effect of primary
language and found no significant association [44-46].
Two studies looked at country at birth as a predictor
for postpartum testing and whereas Morrison et al. in
their study from Australia found no effect of whether
one was born in or outside Australia [44], Lawrence et al.
in their study from the US found that women born
outside the US had significantly higher odds for testing
compared to US born women [43]. Family history of type
2 diabetes did not predict postpartum glucose testing
according to five of the six studies who included it in
their analysis [41,42,44,56,59,60]. Studies have also
looked at employment status [44], antenatal tobacco use
[54], changes in diet [53], changes in exercise [53], and
health insurance status [45,54] without finding significant
associations with postpartum screening.
No studies from low- or middle-income countries have
examined determinants for postpartum screening, but
studies from high-income countries investigating this have
shown inconsistent results or only found statistically insig-
nificant associations when it comes to determinants re-
lated to the GDM screening test conducted during
pregnancy, treatment, obstetric history, current preg-
nancy, demography, weight, lifestyle changes, family his-
tory of type 2 diabetes, and socio-economic factors.
However, having a postpartum visit with an OBGYN
provider seem to increase the likelihood of postpartum
testing and the likelihood is further increased with more
postpartum visits.
Barriers according to women with GDM
Only two studies - one survey and one qualitative study -
asked women with a history of GDM about barriers to
postpartum diabetes screening [50,61]. Keely et al. investi-
gated why women in Ottawa, Canada with a history of
GDM did not complete postpartum screening for diabetes
using an OGTT. By far the most frequent reason was time
pressure, but lost requisition was mentioned by almost
20% respondents [50]. In the qualitative study by Bennet
et al. conducted among women with GDM attending a
high risk obstetric clinical practice in Baltimore, US, a
number of themes were identified including recent deliv-
ery experience and baby’s health issues; adjustment to the
new baby (emotional stress, feeling overwhelmed and lack
of time and burden of child care); concerns about post-
partum and future health (feeling healthy and not in need
for care, and fear of receiving bad news); and experiences
with medical care and services (dissatisfaction with care
and logistics of accessing care) as barriers to postpartum
follow-up care [61].
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Studies have also investigated determinants for main-
taining a healthy lifestyle (diet or exercise) after an index
GDM pregnancy. Hoedjes et al. reported in their study
from the Netherlands that although women expressed
that they intended to live a healthy postpartum lifestyle,
it was generally not achieved [62]. This notion is sup-
ported by two studies from Australia which found that
among women with GDM in the past 6–24 months un-
healthy diet was prevalent [63] and only 33.6% reported
sufficient physical activity [64]. A reason may be that
women with a history of GDM do not perceive them-
selves to be at increased risk of future diabetes. Hence,
Kim et al. examined risk perception for diabetes among
women with a history of GDM in a US population and
found that although 90% of women recognized GDM as
a risk factor for future diabetes, only 16% believed they
themselves were at high risk of developing diabetes,
though the proportion increased to 39% when asked to es-
timate their risk assuming they maintained their current
lifestyle [65]. In a study from Denmark, Stage et al. found
that 40% of women with a history of GDM were very
worried about developing diabetes in the future, 46% were
a little worried and 14% were not worried at all [66]. In
addition, whereas Stage et al. found no correlation between
worrying and postpartum weight loss, Kim et al. found that
women who perceived themselves to be at no or slight risk
of diabetes were less likely to modify their lifestyle [65,66].
In Neufeld’s study among aboriginal women with a history
of GDM or currently experiencing a GDM affected preg-
nancy in Canada it was noted that many women tried to
continue eating healthy postpartum to protect their health;
however, some postpartum women felt they no longer had
to worry about what they were eating as their dietary in-
take would no longer impact the health of the baby [33].
The importance of self-efficacy and social support for
postpartum healthy lifestyle has been investigated for
both diet [63,67] and physical activity [64,67,68]. Zehle
and colleagues investigated cognitive and social factors,
including the role of self-efficacy and social support,
related to postpartum dietary behaviours among women
with recent GDM in Australia [63]. They found that
non-English speaking women consumed less vegetables
and bread and more fried food than English speaking
women. Self-efficacy was associated with high vegetable
consumption, ability to cook healthy foods, and report-
ing that healthy diet is not a difficult change and that
dislike of healthy foods by other household members is
not a barrier for them. Moreover, self-efficacy when busy
and not reporting a dislike of healthy foods by others at
home were associated with high fruit consumption [63].
Focusing on physical activity, Smith and colleagues found
that in multivariate analysis sufficient physical activitywas independently associated with high self-efficacy
and social support; yet more than half of the women
in their Australian study reported never receiving sup-
port in the form of assistance with household work or
others exercising with them [64]. Another Australian
study by Koh et al. found a similar significant association
of social support and self-efficacy for physical activity, but
noted that these concepts could only explain a small pro-
portion of the variance in physical activity among women
with recent GDM in their study population [68]. In their
study from the US, Kim and colleagues examined the as-
sociation between self-efficacy and social support for both
physical activity and diet and found similar results except
that the adjusted association between self-efficacy and
dietary quality just missed significance [67]. The role of
various socio-demographic variables in physical activ-
ity and weight management among women with recent
GDM has been investigated by two Australian studies but
no significant association was noted [68,69].
When it comes to continuing lifestyle modifications
postpartum, studies indicate that intention may be there,
but many women do not succeed in continuing their
modifications. This may be influenced by their percep-
tion of risk of future diabetes and particularly by self-
efficacy and social support.
Barriers for healthy postpartum lifestyle
A number of studies from Australia, US and the
Netherlands have investigated barriers to a healthy post-
partum lifestyle among women with history of GDM
[62,64,70-73]. Lack of time and/or energy was a com-
mon barrier mentioned in all studies [29,62,64,70-73]
and so was lack of child care support [62,70-73]. Other
barriers identified in the studies included not feeling well
and/or emotional distress [72,73]: lack of motivation
[70,71]; financial barriers [70,71]; other domestic respon-
sibilities such as cooking [72]; lack of knowledge [62,64]:
lack of understanding about GDM [62]; lack of social
support [64,70-72] lack of health care provider support
[62]; feeling of solitude, dullness and isolation from fam-
ily and friends [62,70]; poor body image [70]; bad wea-
ther [70]; considering oneself to be too young to be on a
restricted diet [29]; obstacles at work [71]; unsuitable
local neighbourhood or no access to exercise equipment
[64,71]; cultural expectations e.g. needs of women come
last in the family [70,72]; and lack of enjoyment of phys-
ical activity [64]. Moreover, in a study among immigrant
women in Australia it was mentioned that breastfeeding
was a barrier to postpartum weight reduction as it made
them increase their food intake [29].
Discussion
This review of scientific literature on barriers and
determinants for screening, diagnosis, management and
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58 full text papers published in peer reviewed journals.
In the final stage of literature review we excluded 3 non-
English articles. This of course may entail some bias,
missing out some of the additional local issues that may
have been highlighted in these articles. The decision to
limit the search to not include grey literature, reports
and book chapters was made due to allowed journal
space for a review article.
The review does not cover determinants and barriers
to ANC attendance in general. GDM screening will only
occur when women are able to overcome barriers to
ANC attendance in the first place. Others have pub-
lished extensively on determinants and barriers for ANC
attendance [74,75].
There are serious barriers to proper GDM services,
management and care even in high-income countries
and across study settings (see Table 4). Although some
determinants and barriers to GDM management are
consistent across studies, many are contextual or
culture-specific. The barriers operate at different levels –
cultural and societal; health system resources; health care
provider and client characteristics. Lack of knowledge and
perceived seriousness about the issue amongst policy
makers, health care providers, affected women and their
family and lay people in general is perhaps the biggest
hurdle. Compartmentalisation of care is another import-
ant barrier - as noted earlier- not seeing the patient, the
patient being lost to follow-up and lack of communica-
tion/collaboration between health care providers were the
most widely mentioned issues by the health care providers
as barriers to postpartum follow up. Following delivery
women with GDM usually no longer have diabetes and
are no longer pregnant and therefore unlikely to visit phy-
sicians or gynaecologists for check-ups and thus perceived
to be lost to follow-up. However these women do visit
health services focused on the wellbeing of their babies,
for instance for the child’s vaccination program and
follow-up and are likely to do so at regular intervals for at
least five years. So why cannot this opportunity be used to
provide them follow-up advice and conduct necessary
tests? Why cannot the health system tag the mother’s
GDM status to the child for the benefit of both? [76].
Studies have shown that lifestyle modifications and/or
pharmaceutical intervention following a GDM pregnancy
is as effective in preventing or delaying the onset of type 2
diabetes as in the case of other people with pre-diabetes
[12,13,77-79]. Clinical trials now provide grade A evidence
for the impact of multiple interventions to prevent the
progression to type 2 diabetes in women with a history of
GDM. Both lifestyle modification and pharmacological
therapies (metformin, troglitazone, and pioglitazone) have
been shown to reduce diabetes development by 50% or
more [80]. Several prospective studies have been initiatedin different ethnic groups to replicate the findings of these
studies with encouraging initial positive results [81-83].
The diagnosis of GDM should initiate a long-term inter-
vention and diagnostic process to minimize the risk of de-
veloping diabetes or to diagnose it as early in the course
of disease as possible [80]. Moreover, women with one
GDM affected pregnancy are at high risk of developing
GDM in subsequent pregnancies [84]. The need to ad-
dress barriers to postpartum follow-up and lifestyle modi-
fications are therefore imperative. In view of the emerging
burden of GDM in populous low- and middle-income
countries, it is remarkable that all except four of the in-
cluded studies were conducted in high-income countries.
It is equally remarkable that few studies sought to identify
barriers and how they might be overcome by including
the pregnant and postpartum women’s opinions and prop-
ositions, including the role of breastfeeding.
Studies on the magnitude of the GDM burden in
recent years have shown that GDM is a fast growing
problem in low- and middle-income countries. Studies
from South India and China found prevalence rates of
17.8% and 17.5%, respectively [85,86]. At the same time
many developing countries are experiencing rapidly in-
creasing diabetes prevalence rates [87] and continue to
struggle with high rates of maternal mortality and mor-
bidity and inadequate emergency obstetric care [88].
Availability, affordability and access to services for GDM
are likely to be even bigger barriers in low- and middle-
income countries than what has been illustrated in this
review. GDM increases the risk of macrosomia, shoulder
dystocia and obstructed labour and so pregnancies com-
plicated by GDM without proper access to obstetrical
care can be fatal or result in debilitating outcomes. For-
tunately, a number of developing countries have started
to pilot or implement GDM programmes [15]. Health
care providers, health care planners, public health pro-
fessionals and policy makers need to understand and
take these barriers into consideration to ensure proper
initiatives to address GDM are put in place, without for-
getting to involve the women at risk.
Conclusions
This systematic review has evaluated determinants and
barriers to proper GDM services. Very few studies from
low- and middle-income countries were found. Compli-
ance to screening tests was sub-optimal, but little infor-
mation is available on what factors influence poor
compliance and thereby identify what can be done to
improve it. While women express commitment and mo-
tivation for treatment to protect their health and thereby
the health of the unborn baby, behaviour changes and
compliance to treatment are associated with challenges
and a number of barriers have been identified, particularly
in the qualitative studies. Also postpartum screening for
Table 4 Barriers identified in high-income and low- and middle-income countries
High-income countries Low- and middle-income countries
• No studies focusing on barriers to GDM screening and diagnosis
were identified.
• Barriers to GDM screening and diagnosis include difficulties in
screening women during the recommended time period, applicability
and relevance of the risk factors used in selective screening programmes,
challenges in testing women in the fasting state and need for repeat
test, screening procedure being too time consuming, scarcity of test
consumables and lack of equipment.
• Barriers to treatment include lack of social support, stress, cost of
healthy food, cost of health care and medical supplies, lack of
advice and information about diet and exercise, dietary messages
being contradictory, dietary messages being difficult to understand,
lack of trust in messages received from the health care providers,
waiting time to access health care providers for advice, lack of
access to health care and health insurance, pregnancy-related food
preferences and cravings, diet plans being perceived as stressful,
adaptation of unhealthy eating patterns such as bulimia and binging,
frequent use of ‘comfort foods’, difficulty in adhering to a diet when
participating in social gatherings, concerns for baby’s growth and
putting a strain on the baby, reluctance to inject insulin, treatment
being time consuming, lack of knowledge, denial of severity, lack of
motivation, other social barriers.
• Barriers to treatment include confusion over dietary recommendations,
lack of sufficient advice, concerns about the effects of the
recommendations, structural changes such as more cars leading to
reduced physical activity, more unhealthy take away food options and
lower rates of home cooking and eating of traditional foods.
• Barriers to postpartum screening include health care provider not
seeing the patient, the patient being lost to follow-up, lack of
communication/collaboration between health care providers,
inconsistent guidelines or lack of familiarity to guidelines, not aware
about history of GDM, patients not considering the test necessary,
or declining testing, or unable to complete test, testing not affordable,
patient uninformed or lack understanding of need for test, practice
being too busy, time pressure (women), lost requisition, recent
delivery experience, baby’s health issues, adjustment to the new baby
(emotional stress, feeling overwhelmed and lack of time and burden
of child care), concerns about postpartum and future health
(feeling healthy and not in need for care, and fear of receiving
bad news), and experiences with medical care and services
(dissatisfaction with care and logistics of accessing care).
• No studies focusing on barriers to postpartum GDM screening were
identified
• Barriers to healthy postpartum lifestyle include lack of time and/or
energy, lack of child care support, not feeling well, emotional distress,
lack of motivation, financial barriers, domestic responsibilities such
as cooking, lack of knowledge, lack of understanding about GDM,
lack of social support, lack of support from health care provider,
feeling of solitude, dullness and isolation from family and friends,
poor body image, bad weather, considering oneself to be too young
to be on a restricted diet, obstacles at work, unsuitable local
neighbourhood, no access to exercise equipment, cultural
expectations, lack of enjoyment of physical activity, breastfeeding
as it made some women increase their food intake.
No studies focusing on barriers to healthy postpartum lifestyle were
identified
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nants and barriers have been identified, including pa-
tients being lost to follow-up, lack of time and lost
requisition etc. Variable results were found for many de-
terminants. Following a recent GDM pregnancy many
women desire and intend to maintain healthy lifestyles to
prevent future diabetes but find the effort challenging.
Self-efficacy and social support are important deter-
minants in this regard. Understanding determinants and
barriers within the local context is vital in designing public
health interventions to address the growing burden of
GDM and diabetes. Therefore, studies from low- and
middle-income countries where the prevalence of GDM is
rapidly increasing are especially warranted.Competing interests
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